vs

Side-by-side financial comparison of Limbach Holdings, Inc. (LMB) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $138.9M, roughly 1.2× Limbach Holdings, Inc.). Limbach Holdings, Inc. runs the higher net margin — 3.2% vs -82.0%, a 85.1% gap on every dollar of revenue. On growth, Limbach Holdings, Inc. posted the faster year-over-year revenue change (4.3% vs -22.7%). Over the past eight quarters, Limbach Holdings, Inc.'s revenue compounded faster (6.6% CAGR vs -11.5%).

Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

LMB vs PTCT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.2× larger
PTCT
$164.7M
$138.9M
LMB
Growing faster (revenue YoY)
LMB
LMB
+27.1% gap
LMB
4.3%
-22.7%
PTCT
Higher net margin
LMB
LMB
85.1% more per $
LMB
3.2%
-82.0%
PTCT
Faster 2-yr revenue CAGR
LMB
LMB
Annualised
LMB
6.6%
-11.5%
PTCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LMB
LMB
PTCT
PTCT
Revenue
$138.9M
$164.7M
Net Profit
$4.4M
$-135.0M
Gross Margin
22.4%
Operating Margin
0.8%
-43.3%
Net Margin
3.2%
-82.0%
Revenue YoY
4.3%
-22.7%
Net Profit YoY
-104.8%
EPS (diluted)
$0.36
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LMB
LMB
PTCT
PTCT
Q1 26
$138.9M
Q4 25
$186.9M
$164.7M
Q3 25
$184.6M
$211.0M
Q2 25
$142.2M
$178.9M
Q1 25
$133.1M
$1.2B
Q4 24
$143.7M
$213.2M
Q3 24
$133.9M
$196.8M
Q2 24
$122.2M
$186.7M
Net Profit
LMB
LMB
PTCT
PTCT
Q1 26
$4.4M
Q4 25
$12.3M
$-135.0M
Q3 25
$8.8M
$15.9M
Q2 25
$7.8M
$-64.8M
Q1 25
$10.2M
$866.6M
Q4 24
$9.8M
$-65.9M
Q3 24
$7.5M
$-106.7M
Q2 24
$6.0M
$-99.2M
Gross Margin
LMB
LMB
PTCT
PTCT
Q1 26
22.4%
Q4 25
25.7%
Q3 25
24.2%
Q2 25
28.0%
Q1 25
27.6%
Q4 24
30.3%
Q3 24
27.0%
Q2 24
27.4%
Operating Margin
LMB
LMB
PTCT
PTCT
Q1 26
0.8%
Q4 25
9.4%
-43.3%
Q3 25
7.2%
1.4%
Q2 25
7.5%
-19.5%
Q1 25
5.9%
82.5%
Q4 24
9.1%
-76.2%
Q3 24
8.1%
-27.7%
Q2 24
6.7%
-21.5%
Net Margin
LMB
LMB
PTCT
PTCT
Q1 26
3.2%
Q4 25
6.6%
-82.0%
Q3 25
4.8%
7.5%
Q2 25
5.5%
-36.3%
Q1 25
7.7%
73.7%
Q4 24
6.9%
-30.9%
Q3 24
5.6%
-54.2%
Q2 24
4.9%
-53.1%
EPS (diluted)
LMB
LMB
PTCT
PTCT
Q1 26
$0.36
Q4 25
$1.01
$-1.63
Q3 25
$0.73
$0.20
Q2 25
$0.64
$-0.83
Q1 25
$0.85
$10.04
Q4 24
$0.81
$-0.85
Q3 24
$0.62
$-1.39
Q2 24
$0.50
$-1.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LMB
LMB
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$15.8M
$1.9B
Total DebtLower is stronger
$56.6M
Stockholders' EquityBook value
$196.3M
$-205.3M
Total Assets
$377.0M
$2.9B
Debt / EquityLower = less leverage
0.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LMB
LMB
PTCT
PTCT
Q1 26
$15.8M
Q4 25
$11.3M
$1.9B
Q3 25
$9.8M
$1.7B
Q2 25
$38.9M
$2.0B
Q1 25
$38.1M
$2.0B
Q4 24
$44.9M
$1.1B
Q3 24
$51.2M
$1.0B
Q2 24
$59.5M
$1.1B
Total Debt
LMB
LMB
PTCT
PTCT
Q1 26
$56.6M
Q4 25
$30.5M
Q3 25
$56.3M
Q2 25
$28.4M
Q1 25
$23.7M
Q4 24
$23.6M
Q3 24
$20.5M
Q2 24
$19.7M
Stockholders' Equity
LMB
LMB
PTCT
PTCT
Q1 26
$196.3M
Q4 25
$195.7M
$-205.3M
Q3 25
$181.6M
$-155.8M
Q2 25
$170.5M
$-206.5M
Q1 25
$161.1M
$-185.8M
Q4 24
$153.5M
$-1.1B
Q3 24
$142.2M
$-1.1B
Q2 24
$133.0M
$-980.2M
Total Assets
LMB
LMB
PTCT
PTCT
Q1 26
$377.0M
Q4 25
$381.1M
$2.9B
Q3 25
$409.1M
$2.6B
Q2 25
$343.0M
$2.6B
Q1 25
$336.4M
$2.7B
Q4 24
$352.1M
$1.7B
Q3 24
$324.4M
$1.8B
Q2 24
$303.9M
$1.9B
Debt / Equity
LMB
LMB
PTCT
PTCT
Q1 26
0.29×
Q4 25
0.16×
Q3 25
0.31×
Q2 25
0.17×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.14×
Q2 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LMB
LMB
PTCT
PTCT
Operating Cash FlowLast quarter
$-34.3M
Free Cash FlowOCF − Capex
$-36.6M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LMB
LMB
PTCT
PTCT
Q1 26
Q4 25
$28.1M
$-34.3M
Q3 25
$13.3M
$-66.3M
Q2 25
$2.0M
$-58.3M
Q1 25
$2.2M
$870.1M
Q4 24
$19.3M
$-30.0M
Q3 24
$4.9M
$-77.0M
Q2 24
$16.5M
$-71.5M
Free Cash Flow
LMB
LMB
PTCT
PTCT
Q1 26
Q4 25
$27.9M
$-36.6M
Q3 25
$12.8M
$-69.7M
Q2 25
$1.2M
$-59.6M
Q1 25
$11.0K
$868.4M
Q4 24
$18.0M
$-33.8M
Q3 24
$4.6M
$-77.5M
Q2 24
$13.2M
$-78.8M
FCF Margin
LMB
LMB
PTCT
PTCT
Q1 26
Q4 25
14.9%
-22.3%
Q3 25
7.0%
-33.1%
Q2 25
0.8%
-33.3%
Q1 25
0.0%
73.8%
Q4 24
12.5%
-15.8%
Q3 24
3.4%
-39.4%
Q2 24
10.8%
-42.2%
Capex Intensity
LMB
LMB
PTCT
PTCT
Q1 26
Q4 25
0.1%
1.4%
Q3 25
0.3%
1.6%
Q2 25
0.6%
0.7%
Q1 25
1.7%
0.1%
Q4 24
0.9%
1.8%
Q3 24
0.3%
0.3%
Q2 24
2.7%
4.0%
Cash Conversion
LMB
LMB
PTCT
PTCT
Q1 26
Q4 25
2.29×
Q3 25
1.52×
-4.17×
Q2 25
0.26×
Q1 25
0.22×
1.00×
Q4 24
1.96×
Q3 24
0.66×
Q2 24
2.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LMB
LMB

ODR$99.8M72%
GCR$39.0M28%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons